Ketamine: Difference between revisions

From BurnZero
mNo edit summary
mNo edit summary
Line 5: Line 5:


* Dissociation with some patients reporting [[Out of Body Experiences]]  
* Dissociation with some patients reporting [[Out of Body Experiences]]  
* neurocognitive effects  
* Effects similar to those experienced during [[Near Death Experience|Near Death Experiences]].
* Neurocognitive changes similar to the effects of [[stroboscopics]].


=== Abuse ===
=== Abuse ===
Like any drug, overuse is linked to negative effects. It has been found that chronic, uncontrolled use may lead to ketamine-induced ulcerative cystitis and neurocognitive impairment which can impact negatively upon achievement in education and at work, and also compound addiction problems.<ref>Morgan CJ, Curran HV; Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction. 2012 Jan;107(1):27-38. doi: 10.1111/j.1360-0443.2011.03576.x. Epub 2011 Jul 22. PMID: 21777321.</ref>
Like any drug, overuse is linked to negative effects. It has been found that chronic, uncontrolled use may lead to ketamine-induced ulcerative cystitis and neurocognitive impairment which can impact negatively upon achievement in education and at work, and also compound addiction problems.<ref>Morgan CJ, Curran HV; Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction. 2012 Jan;107(1):27-38. doi: 10.1111/j.1360-0443.2011.03576.x. Epub 2011 Jul 22. PMID: 21777321.</ref>

Revision as of 01:50, 6 December 2022

Ketamine has been used as a general anaesthetic for more than 50 years. The medicine has recently garnered prominence as a therapeutic agent used in the treatment of depression[1].

Effects

Ketamine has been shown to cause:

Abuse

Like any drug, overuse is linked to negative effects. It has been found that chronic, uncontrolled use may lead to ketamine-induced ulcerative cystitis and neurocognitive impairment which can impact negatively upon achievement in education and at work, and also compound addiction problems.[2]

  1. Zhang K, Hashimoto K. An update on ketamine and its two enantiomers as rapid-acting antidepressants. Expert Rev Neurother. 2019 Jan;19(1):83-92. doi: 10.1080/14737175.2019.1554434. Epub 2018 Dec 4. PMID: 30513009.
  2. Morgan CJ, Curran HV; Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction. 2012 Jan;107(1):27-38. doi: 10.1111/j.1360-0443.2011.03576.x. Epub 2011 Jul 22. PMID: 21777321.

Share your opinion